People: Procter & Gamble Co (PG.N)

PG.N on New York Stock Exchange

84.45USD
3:19pm EDT
Price Change (% chg)

$0.37 (+0.44%)
Prev Close
$84.08
Open
$83.98
Day's High
$84.49
Day's Low
$83.93
Volume
987,251
Avg. Vol
1,918,023
52-wk High
$85.82
52-wk Low
$75.20

Search Stocks

Desmond-Hellmann, Susan 

Brief Biography

Dr. Susan Desmond-Hellmann, M.D., has been Independent Director of the Procter & Gamble Company. Dr. Desmond-Hellmann is Chancellor and Arthur and Toni Rembe Rock Distinguished Professor, University of California, San Francisco (“UCSF”), where she has served since August 2009. From 2004 through 2009, Dr. Desmond-Hellmann served as president of product development at Genentech (a biotechnology company), where she was responsible for pre-clinical and clinical development, business development, and product portfolio management. Prior to joining Genentech in 1995, Dr. Desmond-Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute. She has been a Director of Facebook Inc. since March 2013. As Chancellor of UCSF, a member of the Howard Hughes Medical Institute board of trustees, Facebook director, and past president of product development at Genentech, Dr. Desmond-Hellmann has extensive leadership and technology experience. As a former member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council, she also brings finance experience to the Board.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alan Lafley

19,504,400

Werner Geissler

7,319,260

Jon Moeller

7,017,860

Giovanni Ciserani

5,142,610

Tarek Farahat

--

Mary Lynn Ferguson-McHugh

--
As Of 29 Jun 2014
Search Stocks